Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1581

1.

Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.

Iwai K, Yaguchi M, Nishimura K, Yamamoto Y, Tamura T, Nakata D, Dairiki R, Kawakita Y, Mizojiri R, Ito Y, Asano M, Maezaki H, Nakayama Y, Kaishima M, Hayashi K, Teratani M, Miyakawa S, Iwatani M, Miyamoto M, Klein MG, Lane W, Snell G, Tjhen R, He X, Pulukuri S, Nomura T.

EMBO Mol Med. 2018 May 16. pii: e8289. doi: 10.15252/emmm.201708289. [Epub ahead of print]

2.

Enhanced Sternal Healing via Platelet-Rich Plasma and Biodegradable Gelatin Hydrogel.

Shibata M, Takagi G, Kudo M, Kurita J, Kawamoto Y, Miyagi Y, Kanazashi M, Sakatani T, Naito Z, Tabata Y, Miyamoto M, Nitta T.

Tissue Eng Part A. 2018 May 16. doi: 10.1089/ten.TEA.2017.0505. [Epub ahead of print]

PMID:
29766749
3.

Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke.

Miyamoto M, Nakamura K, Shichinohe H, Yamauchi T, Ito M, Saito H, Kawabori M, Osanai T, Sasaki T, Houkin K, Kuroda S.

Stem Cells Int. 2018 Apr 8;2018:4829534. doi: 10.1155/2018/4829534. eCollection 2018.

4.

Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.

Ueoka A, Morita H, Watanabe A, Morimoto Y, Kawada S, Tachibana M, Miyamoto M, Nakagawa K, Nishii N, Ito H.

J Am Heart Assoc. 2018 May 10;7(10). pii: e008617. doi: 10.1161/JAHA.118.008617.

5.

A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas.

Soyama H, Miyamoto M, Takano M, Iwahashi H, Kato K, Sakamoto T, Kuwahara M, Ishibashi H, Matuura H, Yoshikawa T, Aoyama T, Tsuda H, Furuya K.

In Vivo. 2018 May-Jun;32(3):597-602.

PMID:
29695566
6.

High Water Tolerance of a Core-Shell-Structured Zeolite for CO2 Adsorptive Separation under Wet Conditions.

Miyamoto M, Ono S, Kusukami K, Oumi Y, Uemiya S.

ChemSusChem. 2018 Apr 19. doi: 10.1002/cssc.201800063. [Epub ahead of print]

PMID:
29673091
7.

β1-integrin is a cell-autonomous factor mediating the Numb pathway for cardiac progenitor maintenance.

Gibbs BC, Shenje L, Andersen P, Miyamoto M, Kwon C.

Biochem Biophys Res Commun. 2018 Jun 2;500(2):256-260. doi: 10.1016/j.bbrc.2018.04.054. Epub 2018 Apr 13.

PMID:
29653101
8.

Ovarian cancer therapeutic potential of glutamine depletion based on GS expression.

Furusawa A, Miyamoto M, Takano M, Tsuda H, Song YS, Aoki D, Miyasaka N, Inazawa J, Inoue J.

Carcinogenesis. 2018 Apr 2. doi: 10.1093/carcin/bgy033. [Epub ahead of print]

PMID:
29617730
9.

Authors' reply to the comments of Kataoka et al. regarding "Could istradefylline be a treatment option for postural abnormalities in mid-stage Parkinson's disease?"

Suzuki K, Miyamoto T, Miyamoto M, Uchiyama T, Hirata K.

J Neurol Sci. 2018 May 15;388:235-236. doi: 10.1016/j.jns.2018.03.019. Epub 2018 Mar 14. No abstract available.

PMID:
29555107
10.

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

Yoshikawa T, Miyamoto M, Aoyama T, Soyama H, Goto T, Hirata J, Suzuki A, Nagaoka I, Tsuda H, Furuya K, Takano M.

Oncol Lett. 2018 Apr;15(4):5772-5780. doi: 10.3892/ol.2018.8028. Epub 2018 Feb 12.

11.

The role of autochthonous organic matter in radioactive cesium accumulation to riverine fine sediments.

Fujii M, Ono K, Yoshimura C, Miyamoto M.

Water Res. 2018 Jun 15;137:18-27. doi: 10.1016/j.watres.2018.02.063. Epub 2018 Mar 2.

PMID:
29522890
12.

Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis.

Takasaki K, Miyamoto M, Takano M, Soyama H, Aoyama T, Matsuura H, Kato K, Sakamoto T, Kuwahara M, Iwahashi H, Ishibashi H, Yoshikawa T, Furuya K.

Cancer Chemother Pharmacol. 2018 May;81(5):809-814. doi: 10.1007/s00280-018-3552-5. Epub 2018 Mar 2.

PMID:
29500481
13.

Sp5 negatively regulates the proliferation of HCT116 cells by upregulating the transcription of p27.

Miyamoto M, Hayashi T, Kawasaki Y, Akiyama T.

Oncol Lett. 2018 Mar;15(3):4005-4009. doi: 10.3892/ol.2018.7793. Epub 2018 Jan 15.

14.

Phosphodiesterase 2A Inhibitor TAK-915 Ameliorates Cognitive Impairments and Social Withdrawal in N-Methyl-d-Aspartate Receptor Antagonist-Induced Rat Models of Schizophrenia.

Nakashima M, Imada H, Shiraishi E, Ito Y, Suzuki N, Miyamoto M, Taniguchi T, Iwashita H.

J Pharmacol Exp Ther. 2018 Apr;365(1):179-188. doi: 10.1124/jpet.117.245506. Epub 2018 Feb 13.

PMID:
29440309
15.

Disinhibited Blink Reflex Recovery Is Related to Lateral Trunk Flexion in Parkinson Disease.

Sugiyama T, Mochizuki H, Hara Y, Miyamoto M, Nakazato Y, Taniguchi A, Ishii N, Shiomi K, Nakazato M.

J Clin Neurophysiol. 2018 Feb 12. doi: 10.1097/WNP.0000000000000457. [Epub ahead of print]

PMID:
29438176
16.

Could istradefylline be a treatment option for postural abnormalities in mid-stage Parkinson's disease?

Suzuki K, Miyamoto T, Miyamoto M, Uchiyama T, Hirata K.

J Neurol Sci. 2018 Feb 15;385:131-133. doi: 10.1016/j.jns.2017.12.027. Epub 2017 Dec 24.

PMID:
29406892
17.

Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis.

Miyamoto M, Takano M, Aoyama T, Soyama H, Yoshikawa T, Tsuda H, Furuya K.

J Gynecol Oncol. 2018 Mar;29(2):e20. doi: 10.3802/jgo.2018.29.e20. Epub 2017 Dec 22.

18.

[Combination Treatments to the Huge Ovarian Cancer with Liver Metastases].

Hasuike Y, Kanaoka Y, Higuchi I, Imoto H, Hosomi S, Ishikawa A, Akiyama Y, Tanigawa T, Miyamoto M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1535-1537. Japanese.

PMID:
29394693
19.

Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma.

Matuura H, Miyamoto M, Takano M, Soyama H, Aoyama T, Yoshikawa T, Kato K, Sakamoto T, Kuwahara M, Takasaki K, Ishibashi H, Iwahashi H, Tsuda H, Furuya K.

Anticancer Res. 2018 Feb;38(2):717-722.

PMID:
29374695
20.

[Two Cases of Colon Metastasis of Gastric Cancer by Different Metastasis Pathway].

Higuchi I, Akiyama Y, Ishikawa A, Hosomi S, Tanigawa T, Hasuike Y, Miyamoto M.

Gan To Kagaku Ryoho. 2018 Jan;45(1):127-129. Japanese.

PMID:
29362330
21.

Reliability of the 123I-mIBG heart/mediastinum ratio: Results of a multicenter test-retest reproducibility study.

Bateman TM, Ananthasubramaniam K, Berman DS, Gerson M, Gropler R, Henzlova M, Mendoza F, Miyamoto M, Shah M, Weiland F.

J Nucl Cardiol. 2018 Jan 17. doi: 10.1007/s12350-017-1183-6. [Epub ahead of print]

PMID:
29344924
22.

Role of endometriosis as a prognostic factor for post-progression survival in ovarian clear cell carcinoma.

Ishibashi H, Takano M, Miyamoto M, Soyama H, Matsuura H, Aoyama T, Yoshikawa T, Kato K, Tsuda H, Furuya K.

Mol Clin Oncol. 2017 Dec;7(6):1027-1031. doi: 10.3892/mco.2017.1468. Epub 2017 Oct 23.

23.

Phenoxodiol Increases Cisplatin Sensitivity in Ovarian Clear Cancer Cells Through XIAP Down-regulation and Autophagy Inhibition.

Miyamoto M, Takano M, Aoyama T, Soyama H, Ishibashi H, Kato K, Iwahashi H, Takasaki K, Kuwahara M, Matuura H, Sakamoto T, Yoshikawa T, Furuya K.

Anticancer Res. 2018 Jan;38(1):301-306.

PMID:
29277787
24.

Temperature-Selective Dual Radical Generation from Alkyl Diiodide: Applications to Synthesis of Asymmetric CABC Multi-Block Copolymers and Their Unique Assembly Structures.

Zheng J, Wang CG, Yamaguchi Y, Miyamoto M, Goto A.

Angew Chem Int Ed Engl. 2018 Feb 5;57(6):1552-1556. doi: 10.1002/anie.201710964. Epub 2018 Jan 16.

PMID:
29266584
25.

Usefulness of multiple chalk-based food colorings for inducing better gene silencing by feeding RNA interference in planarians.

Hattori M, Miyamoto M, Hosoda K, Umesono Y.

Dev Growth Differ. 2018 Jan;60(1):76-81. doi: 10.1111/dgd.12413. Epub 2017 Dec 21.

PMID:
29266402
26.

Sleep disorders in the elderly: Diagnosis and management.

Suzuki K, Miyamoto M, Hirata K.

J Gen Fam Med. 2017 Mar 30;18(2):61-71. doi: 10.1002/jgf2.27. eCollection 2017 Apr. Review.

27.

Detection and validation of predictors of successful extubation in critically ill children.

Toida C, Muguruma T, Miyamoto M.

PLoS One. 2017 Dec 18;12(12):e0189787. doi: 10.1371/journal.pone.0189787. eCollection 2017.

28.

Response to Correspondence "Asymptomatic uterine rupture detected at cesarean section: Some different viewpoints".

Soyama H, Miyamoto M, Sasa H, Ishibashi H, Takano M, Furuya K.

Taiwan J Obstet Gynecol. 2017 Dec;56(6):872. doi: 10.1016/j.tjog.2017.10.031. No abstract available.

29.

Characterization of hybridization within a secondary contact region of the inshore fish, Bostrychus sinensis, in the East China Sea.

Ding S, Mishra M, Wu H, Liang S, Miyamoto MM.

Heredity (Edinb). 2018 Jan;120(1):51-62. doi: 10.1038/s41437-017-0011-8. Epub 2017 Nov 10.

PMID:
29234169
30.

Analysis of arrhythmic events is useful to detect lead failure earlier in patients followed by remote monitoring.

Nishii N, Miyoshi A, Kubo M, Miyamoto M, Morimoto Y, Kawada S, Nakagawa K, Watanabe A, Nakamura K, Morita H, Ito H.

J Cardiovasc Electrophysiol. 2018 Mar;29(3):463-470. doi: 10.1111/jce.13399. Epub 2017 Dec 18.

PMID:
29194831
31.

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene.

Toda A, Sawada K, Yoshimura A, Nakatsuka E, Kuroda H, Kozasa K, Miyamoto M, Hashimoto K, Mabuchi S, Kimura T.

Int J Womens Health. 2017 Nov 13;9:821-825. doi: 10.2147/IJWH.S145805. eCollection 2017.

32.

Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.

Soyama H, Miyamoto M, Takano M, Aoyama T, Matsuura H, Sakamoto T, Takasaki K, Kuwahara M, Kato K, Yoshikawa T, Iwahashi H, Tsuda H, Furuya K.

Med Oncol. 2017 Nov 22;34(12):201. doi: 10.1007/s12032-017-1058-3.

PMID:
29168038
33.

Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.

Miyamoto M, Takano M, Kuwahara M, Soyama H, Kato K, Matuura H, Sakamoto T, Takasaki K, Aoyama T, Yoshikawa T, Furuya K.

Cancer Chemother Pharmacol. 2018 Jan;81(1):111-117. doi: 10.1007/s00280-017-3454-y. Epub 2017 Nov 9.

PMID:
29124328
34.

Discovery of a Novel Series of Pyrazolo[1,5-a]pyrimidine-Based Phosphodiesterase 2A Inhibitors Structurally Different from N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), for the Treatment of Cognitive Disorders.

Mikami S, Kawasaki M, Ikeda S, Negoro N, Nakamura S, Nomura I, Ashizawa T, Kokubo H, Hoffman ID, Zou H, Oki H, Uchiyama N, Hiura Y, Miyamoto M, Itou Y, Nakashima M, Iwashita H, Taniguchi T.

Chem Pharm Bull (Tokyo). 2017;65(11):1058-1077. doi: 10.1248/cpb.c17-00564.

35.

Bioconcentration and Metabolism of Pyriproxyfen in Tadpoles of African Clawed Frogs, Xenopus laevis.

Ose K, Miyamoto M, Fujisawa T, Katagi T.

J Agric Food Chem. 2017 Nov 22;65(46):9980-9986. doi: 10.1021/acs.jafc.7b04184. Epub 2017 Nov 8.

PMID:
29084385
36.

The prevalence, course and clinical correlates of migraine in Parkinson's disease: A multicentre case-controlled study.

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Suzuki S, Haruyama Y, Kobashi G, Hirata K; Kanto NMPD investigators.

Cephalalgia. 2017 Jan 1:333102417739302. doi: 10.1177/0333102417739302. [Epub ahead of print]

PMID:
29073773
37.

[A 70-year-old woman presenting with restless shoulder following posterior internal capsule infarction].

Matsubara T, Suzuki K, Okamura M, Shiina T, Miyamoto M, Nakamura T, Hirata K.

Rinsho Shinkeigaku. 2017 Nov 25;57(11):711-715. doi: 10.5692/clinicalneurol.cn-001048. Epub 2017 Oct 26. Review. Japanese.

PMID:
29070754
38.

Epizootiology of the ectoparasitic protozoans Ichthyobodo salmonis and Trichodina truttae on wild chum salmon Oncorhynchus keta.

Mizuno S, Urawa S, Miyamoto M, Saneyoshi H, Hatakeyama M, Koide N, Ueda H.

Dis Aquat Organ. 2017 Oct 18;126(2):99-109. doi: 10.3354/dao03162.

PMID:
29044040
39.

PACT is required for MDA5-mediated immunoresponses triggered by Cardiovirus infection via interaction with LGP2.

Miyamoto M, Komuro A.

Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):227-233. doi: 10.1016/j.bbrc.2017.10.048. Epub 2017 Oct 12.

PMID:
29032202
40.

Nonclinical safety assessment of SPX-101, a novel peptide promoter of epithelial sodium channel internalization for the treatment of cystic fibrosis.

Walker MP, Cowlen M, Christensen D, Miyamoto M, Barley P, Crowder T.

Inhal Toxicol. 2017 Jul;29(8):356-365. doi: 10.1080/08958378.2017.1366602. Epub 2017 Oct 6.

PMID:
28984146
41.

Measurement of thickness of film deposited on the plasma-facing wall in the QUEST tokamak by colorimetry.

Wang Z, Hanada K, Yoshida N, Shimoji T, Miyamoto M, Oya Y, Zushi H, Idei H, Nakamura K, Fujisawa A, Nagashima Y, Hasegawa M, Kawasaki S, Higashijima A, Nakashima H, Nagata T, Kawaguchi A, Fujiwara T, Araki K, Mitarai O, Fukuyama A, Takase Y, Matsumoto K.

Rev Sci Instrum. 2017 Sep;88(9):093502. doi: 10.1063/1.5000739.

PMID:
28964174
42.

A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.

Watanabe Y, Suzuki K, Miyamoto T, Miyamoto M, Numao A, Fujita H, Uchiyama T, Kadowaki T, Matsubara T, Hirata K.

Intern Med. 2017 Nov 1;56(21):2871-2878. doi: 10.2169/internalmedicine.8565-16. Epub 2017 Sep 25.

43.

Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.

Morita H, Watanabe A, Kawada S, Miyamoto M, Morimoto Y, Nakagawa K, Nishii N, Nakamura K, Ito H.

J Cardiovasc Electrophysiol. 2018 Jan;29(1):107-114. doi: 10.1111/jce.13349. Epub 2017 Oct 11.

PMID:
28940628
44.

Istradefylline improves daytime sleepiness in patients with Parkinson's disease: An open-label, 3-month study.

Suzuki K, Miyamoto M, Miyamoto T, Uchiyama T, Watanabe Y, Suzuki S, Kadowaki T, Fujita H, Matsubara T, Sakuramoto H, Hirata K.

J Neurol Sci. 2017 Sep 15;380:230-233. doi: 10.1016/j.jns.2017.07.045. Epub 2017 Jul 29.

PMID:
28870576
45.

Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Kadowaki T, Hirata K; Kanto NMPD investigators.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):953-959. doi: 10.1136/jnnp-2017-316136. Epub 2017 Aug 28.

46.

Characterizing restless legs syndrome and leg motor restlessness in patients with Parkinson's disease: A multicenter case-controlled study.

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Numao A, Hirata K; Kanto NMPD investigators.

Parkinsonism Relat Disord. 2017 Nov;44:18-22. doi: 10.1016/j.parkreldis.2017.08.007. Epub 2017 Aug 14.

PMID:
28827009
47.

Pregnancy with asymptomatic uterine complete rupture after uterine artery embolization for postpartum hemorrhage.

Soyama H, Miyamoto M, Sasa H, Ishibashi H, Takano M, Furuya K.

Taiwan J Obstet Gynecol. 2017 Aug;56(4):538-540. doi: 10.1016/j.tjog.2016.08.008.

48.

The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways.

Sawai M, Uchida Y, Ohno Y, Miyamoto M, Nishioka C, Itohara S, Sassa T, Kihara A.

J Biol Chem. 2017 Sep 15;292(37):15538-15551. doi: 10.1074/jbc.M117.803171. Epub 2017 Aug 7.

PMID:
28784662
49.

Organosilica Membrane with Ionic Liquid Properties for Separation of Toluene/H₂ Mixture.

Hirota Y, Maeda Y, Yamamoto Y, Miyamoto M, Nishiyama N.

Materials (Basel). 2017 Aug 3;10(8). pii: E901. doi: 10.3390/ma10080901.

50.

Response to letter to the editor "Prophylactic use of Bakri balloon for reduction of hemorrhage at cesarean for placenta previa: addition and clarification".

Soyama H, Miyamoto M, Furuya K.

Arch Gynecol Obstet. 2017 Sep;296(3):615. doi: 10.1007/s00404-017-4476-8. Epub 2017 Jul 26. No abstract available.

PMID:
28748337

Supplemental Content

Loading ...
Support Center